Hearing Loss Trial, Recruiting NCT07028658 Sponsor: Institut Pasteur Condition: Hearing Loss
Back to Hearing Loss

Hearing Loss Trial, Recruiting

NCT07028658
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years old or older
  • You are covered by a social security/health insurance system
  • You have moderate to severe hearing loss in both ears that developed after you learned to speak, and you have been wearing hearing aids for more than 6 months
  • You wear your hearing aids for at least 8 hours a day on average over the past month
  • You can understand speech well in quiet environments (a specific hearing test score is used to measure this — confirm with trial site)
  • You find it difficult to hear in noisy environments, rating your difficulty more than 6 out of 10
  • You have at least an intermediate level of understanding of the French language (roughly able to understand everyday conversations)
  • You are willing to attend speech therapy sessions twice a week as part of the trial

Who may not be able to join:

  • You have already received speech therapy as part of your hearing loss treatment
  • You have been diagnosed with a brain-related degenerative disease, or have a history of brain injury such as a stroke, head injury, brain tumour, or meningitis
  • You have uncorrected vision problems that affect your ability to lip-read, such as macular degeneration, glaucoma, or a cataract that has not been operated on
  • You have severe ringing or noise in your ears (tinnitus), based on a specific questionnaire score (confirm with trial site)
  • You have significant difficulties with memory or thinking, based on specific cognitive assessment scores (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Institut Pasteur
Registry
ClinicalTrials.gov
Start date
16 October 2025
Est. completion
1 September 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Repetition score, in words (with and without labial doppelganger) of Lafon's cochlear lists presented on video support in visual-only modality; Repetition score, in visemes (with and without labial doppelganger) of Lafon's cochlear lists presented on video support in visual-only modality

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov